Investing.com - Generation Bio (NASDAQ: GBIO) reported fourth quarter EPS of $-0.49, worse than the analyst estimate of $-0.48. Revenue for the quarter came in at $2.12M versus the consensus estimate of $1.26M.
Generation Bio's stock price closed at $2.10. It is up 73.55% in the last 3 months and down -47.89% in the last 12 months.
Generation Bio saw 4 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Generation Bio's stock price’s past reactions to earnings here.
According to InvestingPro, Generation Bio's Financial Health score is "fair performance".
Check out Generation Bio's recent earnings performance, and Generation Bio's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar